Related Experiment Video
Updated: Apr 16, 2026

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
Published on: March 7, 2019
Drug synergy drives conserved pathways to increase fission yeast lifespan
Xinhe Huang1, Markos Leggas2, Robert C Dickson3
1Department of Molecular and Cellular Biochemistry and the Lucille Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America. nc.ude.utjws.emoh@gnauhehnix.
Abstract:
Aging occurs over time with gradual and progressive loss of physiological function. Strategies to reduce the rate of functional loss and mitigate the subsequent onset of deadly age-related diseases are being sought. We demonstrated previously that a combination of rapamycin and myriocin reduces age-related functional loss in the Baker's yeast Saccharomyces cerevisiae and produces a synergistic increase in lifespan. Here we show that the same drug combination also produces a synergistic increase in the lifespan of the fission yeast Schizosaccharomyces pombe and does so by controlling signal transduction pathways conserved across a wide evolutionary time span ranging from yeasts to mammals. Pathways include the target of rapamycin complex 1 (TORC1) protein kinase, the protein kinase A (PKA) and a stress response pathway, which in fission yeasts contains the Sty1 protein kinase, an ortholog of the mammalian p38 MAP kinase, a type of Stress Activated Protein Kinase (SAPK). These results along with previous studies in S. cerevisiae support the premise that the combination of rapamycin and myriocin enhances lifespan by regulating signaling pathways that couple nutrient and environmental conditions to cellular processes that fine-tune growth and stress protection in ways that foster long term survival. The molecular mechanisms for fine-tuning are probably species-specific, but since they are driven by conserved nutrient and stress sensing pathways, the drug combination may enhance survival in other organisms.
Insights
Combining rapamycin and myriocin extends lifespan in yeast by regulating conserved nutrient and stress pathways. This drug combination may enhance survival and longevity in other species by fine-tuning cellular processes.
Area of Science:
- Gerontology
- Molecular Biology
- Yeast Genetics
Background:
- Aging is characterized by progressive physiological decline and increased susceptibility to age-related diseases.
- Strategies to slow aging and extend healthspan are critical for public health.
- Previous studies showed rapamycin and myriocin synergistically increase lifespan in Saccharomyces cerevisiae.
Purpose of the Study:
- To investigate the effects of rapamycin and myriocin combination on lifespan in Schizosaccharomyces pombe.
- To identify conserved signaling pathways regulated by this drug combination.
- To explore the potential of this combination for promoting longevity across species.
Main Methods:
- Lifespan analysis in Schizosaccharomyces pombe treated with rapamycin and myriocin.
- Investigation of conserved signaling pathways including TORC1, PKA, and stress response pathways (Sty1/p38 MAP kinase).
Main Results:
- The combination of rapamycin and myriocin synergistically increased lifespan in Schizosaccharomyces pombe.
- This lifespan extension was associated with the regulation of conserved signaling pathways.
- Key pathways modulated include the target of rapamycin complex 1 (TORC1), protein kinase A (PKA), and the Sty1 stress response pathway.
Conclusions:
- The rapamycin and myriocin combination extends lifespan in fission yeast by modulating conserved nutrient and stress signaling pathways.
- These findings suggest that targeting conserved pathways with this drug combination could be a strategy for enhancing longevity.
- The conserved nature of these pathways indicates potential applicability to other organisms, including mammals.
More Related Videos
Related Concept Videos
Bioreactor Controls-III
Gene Regulation During Sporulation
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

